High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma.

Li, Mingxuan; Shen, Yutao; Xiong, Yujia; Bai, Jiwei; Wang, Shuai; Li, Chuzhong; Zhang, Yazhuo

Li, Mingxuan; Shen, Yutao; Xiong, Yujia; Bai, Jiwei; Wang, Shuai; Li, Chuzhong; Zhang, Yazhuo.

Afiliación

Li M; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.
Shen Y; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.
Xiong Y; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.
Bai J; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
Wang S; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.
Li C; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.
Zhang Y; Beijing Neurosurgical Institute, Capital Medical University, Beijing, People's Republic of China.

Onco Targets Ther ; 14: 5435-5445, 2021.

Article en En | MEDLINE | ID: mdl-34924760

Palabras clave

biomarker; mean corpuscular volume; red cell distribution width; skull base chordoma; survival analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Onco Targets Ther Año: 2021 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google